References
- Alván G, Karlsson KK, Villén T. Reversible hearing impairment related to quinine blood concentrations in guinea pig. Life Sci 1989; 45: 751–5
- Alván G, Karlsson K K, Hellgren U, Villén T. Hearing impairment related to quinine plasma concentrations in healthy volunteers. Br J Clin Pharmacol 1991; 31: 409–12
- Paintaud G, Alván G, Berninger E, Gustavsson L, Idrizbegovic E, Karlsson K K, Wakelkamp M. The concentration-effect relationship of quinine-induced hearing impairment. Clin Pharmacol Ther 1994; 55: 317–23
- Karlsson K K, Berninger E, Gustavsson L, Alván G. Pronounced quinine-induced cochlear hearing loss. A mechanistic study in one volunteer at multiple stable plasma concentrations. J Aud Med 1995; 4: 12–24
- Jastreboff P J, Brennan J F, Sasaki CT. Phantom auditory sensations in rats: an animal model for tinnitus. Behav Neurosci 1988; 102: 811–22
- Jastreboff P J, Brennan J F, Sasaki CT. Quinine-induced tinnitus in rats. Arch Otolaryngol Head Neck Surg 1991; 117: 1162–6
- Theophold H-M. A new therapy concept for inner ear illness. Laryngol Rhinol Otol 1985; 64: 609–13
- Jasterboff P J, Brennan JF. Specific effects of ni-modipine on the auditory system. Ann New York Acad Sci 1988; 522: 716–8
- Bobbin R P, Jastreboff P J, Fallon M, Littman T. Ni-modipine, an L-channel Ca2+ antagonist, reverses the negative summating potential recorded from the guinea pig cochlea. Hear Res 1990; 46: 277–88
- Bean BP. Pharmacology of calcium channels in cardiac muscle, vascular muscle and neurons. Am J Hypertension 1991; 406S–11S
- Lin X, Hume R I, Nutall AL. Dihydropyridines and verapamil inhibit voltage-dependent K+ current in isolated outer hair cells of the guinea pig. Hear Res 1995; 88: 36–46
- OhmOri H. Studies of ionic currents in isolated vestibular hair cell of the chich. J Physiol (Lond) 1984; 350: 561–81
- Puel J-L, Bobbin R P, Fallon M. Salicylate, mefena-mate, meclofenamate and quinine on cochlear potentials. Otolaryngol–Head Neck Surg 1990; 102: 66–73
- Kazda S, Towart R. Nimodipine, a new calcium antagonistic drug with a preferential cerebrovascular action. Acta Neurochirurgica 1982; 63: 259–65
- Sciabine A, Schuurman T, Traber J. Pharmacological basis for the use of nimodipine in central nervous system disorders. A review. FASEB 1989; 3: 1799–806
- Kerkhoff W van den, Drewes LR. Transfer of the Ca-antagonists nifedipine and nimodipine across the blood-brain barrier and their regional distribution in vivo. J Cereb Blood Flow Metab 1985; 459–60, Suppl I 5